Literature DB >> 19903819

Isolation of novel animal cell lines defective in glycerolipid biosynthesis reveals mutations in glucose-6-phosphate isomerase.

Jorge F Haller1, Conor Smith, Dailan Liu, Hongying Zheng, Keith Tornheim, Gil-Soo Han, George M Carman, Raphael A Zoeller.   

Abstract

Glycerolipids are structural components for membranes and serve in energy storage. We describe here the use of a photodynamic selection technique to generate a population of Chinese hamster ovary cells that display a global deficiency in glycerolipid biosynthesis. One isolate from this population, GroD1, displayed a profound reduction in the synthesis of phosphatidylcholine, phosphatidylethanolamine, and triglycerides but presented high levels of phosphatidic acid and normal levels of phosphatidylinositol synthesis. This was accompanied by a reduction in phosphatidate phosphatase 1 (PAP1) activity. Expression cloning and sequencing of the cDNA obtained from GroD1 revealed a point mutation, Gly-189 --> Glu, in glucose-6-phosphate isomerase (GPI), a glycolytic enzyme involved in an inherited disorder that results in anemia and neuromuscular symptoms in humans. GPI activity was reduced by 87% in GroD1. No significant differences were found in DNA synthesis, protein synthesis, and ATP levels, whereas glycerol 3-phosphate levels were increased in the mutant. Expression of wild-type hamster GPI restored GPI activity, glycerolipid biosynthesis, and PAP1 activity in GroD1. Two additional, independently isolated GPI-deficient mutants displayed similar phenotypes with respect to PAP1 activity and glycerolipid biosynthesis. These findings uncover a novel relationship between GPI, involved in carbohydrate metabolism, and PAP1, a lipogenic enzyme. These results may also help to explain neuromuscular symptoms associated with inherited GPI deficiency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903819      PMCID: PMC2801288          DOI: 10.1074/jbc.M109.068213

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  An animal cell mutant with a deficiency in acyl/alkyl-dihydroxyacetone-phosphate reductase activity. Effects on the biosynthesis of ether-linked and diacyl glycerolipids.

Authors:  P F James; A C Lake; A K Hajra; L K Larkins; M Robinson; F G Buchanan; R A Zoeller
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

2.  Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation.

Authors:  C A Langner; E H Birkenmeier; K A Roth; R T Bronson; J I Gordon
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

3.  The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer.

Authors:  M Baumann; A Kappl; T Lang; K Brand; W Siegfried; E Paterok
Journal:  Cancer Invest       Date:  1990       Impact factor: 2.176

4.  Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.

Authors:  H Watanabe; K Takehana; M Date; T Shinozaki; A Raz
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

5.  Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages.

Authors:  J Balsinde; E A Dennis
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

6.  GPI Mount Scopus--a variant of glucosephosphate isomerase deficiency.

Authors:  O Shalev; R S Shalev; L Forman; E Beutler
Journal:  Ann Hematol       Date:  1993-10       Impact factor: 3.673

7.  A somatic cell mutant defective in phosphatidylglycerophosphate synthase, with impaired phosphatidylglycerol and cardiolipin biosynthesis.

Authors:  T Ohtsuka; M Nishijima; Y Akamatsu
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

8.  A gene encoding sn-glycerol 3-phosphate dehydrogenase (NAD+) complements an osmosensitive mutant of Saccharomyces cerevisiae.

Authors:  K Larsson; R Ansell; P Eriksson; L Adler
Journal:  Mol Microbiol       Date:  1993-12       Impact factor: 3.501

9.  Glucose-6-phosphate isomerase deficiency associated with nonspherocytic hemolytic anemia in the mouse: an animal model for the human disease.

Authors:  S Merkle; W Pretsch
Journal:  Blood       Date:  1993-01-01       Impact factor: 22.113

10.  The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase.

Authors:  W Xu; K Seiter; E Feldman; T Ahmed; J W Chiao
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

View more
  2 in total

1.  Glucose-6-phosphate isomerase deficiency results in mTOR activation, failed translocation of lipin 1α to the nucleus and hypersensitivity to glucose: Implications for the inherited glycolytic disease.

Authors:  Jorge F Haller; Sarah A Krawczyk; Lubov Gostilovitch; Barbara E Corkey; Raphael A Zoeller
Journal:  Biochim Biophys Acta       Date:  2011-07-21

2.  A cell-based high-throughput screen identifies tyrphostin AG 879 as an inhibitor of animal cell phospholipid and fatty acid biosynthesis.

Authors:  Raphael A Zoeller; Kathleen Geoghegan-Barek
Journal:  Biochem Biophys Rep       Date:  2019-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.